Investigation of Dysynchrony in Patients With Pulmonary Hypertension
Part of paid clinical trials in Stanford, California.
- Sponsor
- Stanford University
- Study ID
- NCT01571700
- Status
- Enrolling By Invitation
Conditions
- Pulmonary Hypertension
Eligibility Criteria
- Sex
- ALL
- Age
- 5 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Catheterization Pacing — PROCEDUREThe second part of the study will include patients with pulmonary hypertension \>5 who are scheduled for a cardiac catheterization for clinical reasons. We will at the conclusion of the routine catheterization, place two pacing catheters within the right atrium and right ventricle and pace the heart at a rate approximately 10% higher than sinus rhythm for 5 minutes. We will then measure dP/dT max in the ventricles, blood pressure and cardiac output using a Fick equation to assess hemodynamics. We will repeat this 3 times using different sites in the right ventricle while simultaneously obtaining echoes to assess mechanical synchrony.
Study Details
The purpose of the study is to determine whether patients with pulmonary hypertension (PH) have dysynchrony, and if so whether it is electrical or mechanical. Once this has been determined, during a catheterization the investigators will test if pacing the heart improves blood circulation.
Key Dates
- Start date
- Sep 30, 2006
- Status verified
- Dec 2024
- Primary completion
- Dec 31, 2029
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: StudyPatients with pulmonary hypertension.
- Arm: ControlASD patients or patients with normal hearts
Primary Outcome Measure
Electrical or Mechanical Dysynchrony [ Time Frame: Open ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford Hospital | Stanford | California | 94305 | - |
Find similar trials in Stanford, CA
By research site
Related Studies
- MRI and Computational Simulation Cardiology StudyEnrolling By Invitation · Stanford University · Palo Alto, California
- Metformin for Pulmonary Hypertension HFpEFPHASE2 · Recruiting · University of California, San Francisco · San Francisco, California
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pulmonary Hypertension Association RegistryRecruiting · Pulmonary Hypertension Association, Inc. · Phoenix, Arizona